Family compliance to a treatment programme for alcoholics: a prospective study of prognostic factors.
A total of 198 alcoholic subjects was recruited into a treatment programme according to Hudolin's method. The programme included three steps: (1) presentation of the programme to the alcoholic family (four meetings); (2) a therapeutic community that met weekly over 4 months; and (3) attendance at an on-Treatment Alcoholic Club located close to the family's home residence (weekly self-conducted meetings). Data on the families' compliance to the treatment programme were obtained in January 1993 and the prognostic significance of 11 variables collected during the first step was determined by the proportional hazards regression model. The cumulative proportion of family compliance after 40 months was 36.4%, with similar drop-out rates at each of the three steps of the programme. The prognostic factor which was the major determinant of family compliance to treatment was the active presence of the whole family in the first step, while a good job performance was independently associated with family compliance, being a significant prognostic factor in the second step of the programme. Alcohol abstinence was obtained in 35.9% of the whole study group. This programme provided results for alcohol abstinence which are comparable with methods that require more expensive resources.
Arico
S
S
Division of Gastroenterology, Ospedale Mauriziano Umberto I, Torino, Italy.
Zannero
A
A
Galatola
G
G
Valenti
M
M
Corrao
G
G
D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000523:psychology / Q000534:rehabilitation*; D017004:Codependency, Psychological; D003131:Combined Modality Therapy; D005196:Family Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance / Q000523:psychology*; D010352:Patient Dropouts / Q000523:psychology; D011379:Prognosis; D011446:Prospective Studies; D012050:Rehabilitation, Vocational / Q000523:psychology; D012657:Self-Help Groups; D012944:Social Support; D013808:Therapeutic Community; D016896:Treatment Outcome